Advertisement
Advertisement
U.S. markets close in 4 hours 55 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Spectral Medical Inc. (SD4.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.2380+0.0040 (+1.71%)
As of 08:19AM CET. Market open.
Advertisement
Full screen
Loading interactive chart...
  • Simply Wall St.

    Spectral Medical Third Quarter 2022 Earnings: Misses Expectations

    Spectral Medical ( TSE:EDT ) Third Quarter 2022 Results Key Financial Results Revenue: CA$374.0k (up 63% from 3Q 2021...

  • GlobeNewswire

    Spectral Medical Announces Third Quarter Results and Provides Corporate Update

    TORONTO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly-owned subsidiary Dialco Medical Inc. (“Dialco”), today announced its financial results for the third quarter ended September 30, 2022 and provided a corporate update. Chris Seto, CE

  • GlobeNewswire

    Spectral Medical Inc. Closes $10.8 Million Public Offering and Concurrent Private Placement

    NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the “Company”) is pleased to announce that it has closed its previously announced prospectus offering of units (the “Units”) of the Company (the “Unit Offering”) and concurrent private placement (the “Note Offering” and together with the Unit Offering, the “Offering”) of US$5 million of convertible senior note

Advertisement
Advertisement